Pulmonary Rehabilitation Principles in SARS-COV-2 Infection (COVID-19): A Guideline for the Acute and Subacute Rehabilitation

Overview

Journal Turk J Phys Med Rehabil

Specialty Rehabilitation Medicine

Date 2020 Aug 8

PMID 32760887

Citations 37

Authors

Yesim Kurtais Aytur

Belma Fusun Koseoglu

Ozden Ozyemisci Taskiran

Nilufer Kutay Ordu-Gokkaya

Sibel Unsal Delialioglu

Birkan Sonel Tur

Selda Sarikaya

Hulya Sirzai

Tulay Tekdemir Tiftik

Ebru Alemdaroglu

F Figen Ayhan

Burcu Duyur Duyur Cakit

Aysun Genc

Ibrahim Gundogdu

Rengin Guzel

Derya Demirbag Karayel

Basak Bilir Kaya

Oznur Oken

Hande Ozdemir

Feray Soyupek

Canan Tikiz

Affiliations

Soon will be listed here.

Abstract

Coronavirus disease 2019 (COVID-19) is a contagious infection disease, which may cause respiratory, physical, psychological, and generalized systemic dysfunction. The severity of disease ranges from an asymptomatic infection or mild illness to mild or severe pneumonia with respiratory failure and/or death. COVID-19 dramatically affects the pulmonary system. There is a lack of knowledge about the long-term outcomes of the disease and the possible sequelae and rehabilitation. This clinical practice guideline includes pulmonary rehabilitation (PR) recommendations for adult COVID-19 patients and has been developed in the light of the guidelines on the diagnosis and treatment of COVID-19 provided by the World Health Organization and Republic of Turkey, Ministry of Health, recently published scientific literature, and PR recommendations for COVID-19 regarding basic principles of PR. In this guideline, the contagiousness of COVID-19, recommendations on limited contact of patient with healthcare providers, and the evidence about possible benefits of PR were taken into consideration.

Citing Articles

The process of obtaining information about COVID-19 among students of physiotherapy and rehabilitation department.

Gunduz D, Secer E, Secer M BMC Med Educ. 2025; 25(1):189.

PMID: 39915789 PMC: 11800398. DOI: 10.1186/s12909-025-06764-0.

Design, implementation, and evaluation of a virtual pulmonary rehabilitation training course for medical interns in COVID-19.

Mianehsaz E, Zobeidy E, Azadchehr M, Abrahimi A, Faghihi A J Educ Health Promot. 2024; 13:154.

PMID: 38784270 PMC: 11114579. DOI: 10.4103/jehp.jehp_527_23.

Knowledge and perceptions regarding pulmonary rehabilitation amongst Ecuadorian physicians following COVID-19 outbreak.

Felix M, Vanegas E, Sarfraz A, Sarfraz Z, Camacho G, Barrios-Ruiz A Multidiscip Respir Med. 2024; 19(1):919.

PMID: 38516292 PMC: 10956887. DOI: 10.5826/mrm.2024.919.

Clinical manifestations of pain in patients suffering from COVID-19 infected with Delta variant of SARS-Cov-2.

Mohammadian Erdi A, Zakavi M, Amani M, Fooladi S, Abedi A Front Pain Res (Lausanne). 2023; 4:1282527.

PMID: 38034880 PMC: 10684905. DOI: 10.3389/fpain.2023.1282527.

Implementation of Early Rehabilitation in Severe COVID-19 Respiratory Failure: A Scoping Review.

Miner D, Smith K, Foroozesh M, Price J J Acute Care Phys Ther. 2023; 14(2):63-77.

PMID: 36968180 PMC: 10032217. DOI: 10.1097/JAT.0000000000000204.

References

Chiumello D, Coppola S, Froio S, Gotti M . What's Next After ARDS: Long-Term Outcomes. Respir Care. 2016; 61(5):689-99. DOI: 10.4187/respcare.04644. View

Andrianopoulos V, Klijn P, Franssen F, Spruit M . Exercise training in pulmonary rehabilitation. Clin Chest Med. 2014; 35(2):313-22. DOI: 10.1016/j.ccm.2014.02.013. View

Guo Y, Cao Q, Hong Z, Tan Y, Chen S, Jin H . The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020; 7(1):11. PMC: 7068984. DOI: 10.1186/s40779-020-00240-0. View

Lazzeri M, Lanza A, Bellini R, Bellofiore A, Cecchetto S, Colombo A . Respiratory physiotherapy in patients with COVID-19 infection in acute setting: a Position Paper of the Italian Association of Respiratory Physiotherapists (ARIR). Monaldi Arch Chest Dis. 2020; 90(1). DOI: 10.4081/monaldi.2020.1285. View

Singhal T . A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr. 2020; 87(4):281-286. PMC: 7090728. DOI: 10.1007/s12098-020-03263-6. View

Nathens A, Neff M, Jurkovich G, Klotz P, Farver K, Ruzinski J . Randomized, prospective trial of antioxidant supplementation in critically ill surgical patients. Ann Surg. 2002; 236(6):814-22. PMC: 1422648. DOI: 10.1097/00000658-200212000-00014. View

Wang Y, Zhang D, Du G, Du R, Zhao J, Jin Y . Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial. Lancet. 2020; 395(10236):1569-1578. PMC: 7190303. DOI: 10.1016/S0140-6736(20)31022-9. View

Wan Y, Shang J, Graham R, Baric R, Li F . Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. J Virol. 2020; 94(7). PMC: 7081895. DOI: 10.1128/JVI.00127-20. View

Kooraki S, Hosseiny M, Myers L, Gholamrezanezhad A . Coronavirus (COVID-19) Outbreak: What the Department of Radiology Should Know. J Am Coll Radiol. 2020; 17(4):447-451. PMC: 7102595. DOI: 10.1016/j.jacr.2020.02.008. View

10.

Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N . A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circ Res. 2000; 87(5):E1-9. DOI: 10.1161/01.res.87.5.e1. View

11.

Yang F, Liu N, Hu J, Wu L, Su G, Zhong N . [Pulmonary rehabilitation guidelines in the principle of 4S for patients infected with 2019 novel coronavirus (2019-nCoV)]. Zhonghua Jie He He Hu Xi Za Zhi. 2020; 43(3):180-182. DOI: 10.3760/cma.j.issn.1001-0939.2020.03.007. View

12.

Doiron K, Hoffmann T, Beller E . Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit. Cochrane Database Syst Rev. 2018; 3:CD010754. PMC: 6494211. DOI: 10.1002/14651858.CD010754.pub2. View

13.

Patel V, Dial K, Wu J, Gauthier A, Wu W, Lin M . Dietary Antioxidants Significantly Attenuate Hyperoxia-Induced Acute Inflammatory Lung Injury by Enhancing Macrophage Function via Reducing the Accumulation of Airway HMGB1. Int J Mol Sci. 2020; 21(3). PMC: 7037000. DOI: 10.3390/ijms21030977. View

14.

Fowler 3rd A, Truwit J, Hite R, Morris P, DeWilde C, Priday A . Effect of Vitamin C Infusion on Organ Failure and Biomarkers of Inflammation and Vascular Injury in Patients With Sepsis and Severe Acute Respiratory Failure: The CITRIS-ALI Randomized Clinical Trial. JAMA. 2019; 322(13):1261-1270. PMC: 6777268. DOI: 10.1001/jama.2019.11825. View

15.

Wu P, Duan F, Luo C, Liu Q, Qu X, Liang L . Characteristics of Ocular Findings of Patients With Coronavirus Disease 2019 (COVID-19) in Hubei Province, China. JAMA Ophthalmol. 2020; 138(5):575-578. PMC: 7110919. DOI: 10.1001/jamaophthalmol.2020.1291. View

16.

Sawicki S, Sawicki D . Coronavirus transcription: a perspective. Curr Top Microbiol Immunol. 2004; 287:31-55. PMC: 7121018. DOI: 10.1007/3-540-26765-4_2. View

17.

Vitacca M, Carone M, Clini E, Paneroni M, Lazzeri M, Lanza A . Joint Statement on the Role of Respiratory Rehabilitation in the COVID-19 Crisis: The Italian Position Paper. Respiration. 2020; 99(6):493-499. PMC: 7316664. DOI: 10.1159/000508399. View

18.

Sigurdsson M, Sigvaldason K, Gunnarsson T, Moller A, Sigurdsson G . Acute respiratory distress syndrome: nationwide changes in incidence, treatment and mortality over 23 years. Acta Anaesthesiol Scand. 2012; 57(1):37-45. DOI: 10.1111/aas.12001. View

19.

Bolton C, Bevan-Smith E, Blakey J, Crowe P, Elkin S, Garrod R . British Thoracic Society guideline on pulmonary rehabilitation in adults. Thorax. 2013; 68 Suppl 2:ii1-30. DOI: 10.1136/thoraxjnl-2013-203808. View

20.

Zhou P, Yang X, Wang X, Hu B, Zhang L, Zhang W . A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020; 579(7798):270-273. PMC: 7095418. DOI: 10.1038/s41586-020-2012-7. View